Business Development
Cellics is open to collaborating to advance the development of CNP Technology to improve patient health.
Collaboration & Business Inquires: bd@cellics.com
Current Collaborations
Professor Liangfang Zhang’s group at UCSD invented Cellular Nanoparticle (CNP) platform technology, from which Cellics aims to advance therapeutics and innovative drug delivery to broadly improve the lives of people suffering from serious diseases. Cellics and UCSD have a close collaboration to further develop cellular nanosponge technology and CNP drug delivery.
Cellics and CARB-X have a strategic partnership of up to $15 Million to develop a novel macrophage nanosponge for treating sepsis and CAR-T Cytokine Release Syndrome (CRS). CARB-X will be supporting Cellics through pre-clinical to Phase-1 to further clinical development and obtain regulatory approval.